C
Caroline S. Verbeke
Researcher at University of Oslo
Publications - 181
Citations - 8646
Caroline S. Verbeke is an academic researcher from University of Oslo. The author has contributed to research in topics: Pancreatic cancer & Cancer. The author has an hindex of 39, co-authored 170 publications receiving 7226 citations. Previous affiliations of Caroline S. Verbeke include Karolinska Institutet & Oslo University Hospital.
Papers
More filters
Journal ArticleDOI
Guidelines for the management of gastroenteropancreatic neuroendocrine (including carcinoid) tumours (NETs)
John Ramage,A Ahmed,J Ardill,N.D.S. Bax,David J. Breen,Martyn Caplin,Pippa Corrie,J Davar,Albert Davies,Val Lewington,Tim Meyer,John Newell-Price,Graeme J. Poston,N. Reed,Andrea Rockall,William P. Steward,Rajesh V. Thakker,C. Toubanakis,Juan W. Valle,Caroline S. Verbeke,Ashley B. Grossman +20 more
TL;DR: These guidelines update previous guidance published in 2005 and have been revised by a group who are members of the UK and Ireland Neuroendocrine Tumour Society with endorsement from the clinical committees of the British Society of Gastroenterology and others.
Journal ArticleDOI
European evidence-based guidelines on pancreatic cystic neoplasms
Marco Del Chiaro,Marc G. Besselink,Lianne Scholten,Marco J. Bruno,Djuna L. Cahen,Thomas M. Gress,Jeanin E. van Hooft,Markus M. Lerch,Julia Mayerle,Thilo Hackert,Sohei Satoi,Alessandro Zerbi,David Cunningham,Claudio De Angelis,Marc Giovanni,Enrique de-Madaria,Péter Hegyi,Jonas Rosendahl,Helmut Friess,Riccardo Manfredi,Philippe Lévy,Francisco X. Real,Alain Sauvanet,Mohammed Abu Hilal,Giovanni Marchegiani,Irene Esposito,Paula Ghaneh,Marc R. W. Engelbrecht,Paul Fockens,Nadine C.M. van Huijgevoort,Christopher L. Wolfgang,Claudio Bassi,Natalya Gubergrits,Caroline S. Verbeke,Günter Klöppel,Aldo Scarpa,Giuseppe Zamboni,Anne Marie Lennon,Malin Sund,Nikolaos Kartalis,Lars Grenacher,Massimo Falconi,Urban Arnelo,Kostantin V. Kopchak,Kofi Oppong,Colin J. McKay,Truls Hauge,Kevin C. Conlon,Mustapha Adham,Güralp O. Ceyhan,Roberto Salvia,Christos Dervenis,Peter J. Allen,François Paye,Detlef K. Bartsch,Matthias Löhr,Massimiliano Mutignani,Johanna Laukkarinen,Richard D. Schulick,Roberto Valente,Thomas Seufferlein,Gabriele Capurso,Ajith K. Siriwardena,John P. Neoptolemos,Aldis Pukitis,Ralf Segersvärd,Ali A. Aghdassi,Stefano Andrianello,Peter Bossuyt,Robin Bülow,Karina Cárdenas-Jaén,P. Cortegoso,Martina Fontana,Lena Haeberle,M. Heckler,Andrey Litvin,Kulbir Mann,Christoph W. Michalski,Patrick Michl,Gennaro Nappo,Giampaolo Perri,S. Persson,F. Scheufele,Francesco Sclafani,Manuel Schmidt,L. Venezia,F. Volker,M-P Vullierm,L. Wusten +88 more
TL;DR: A conservative approach is recommended for asymptomatic MCN and IPMN, and Lifelong follow-up of IPMN is recommended in patients who are fit for surgery.
Journal ArticleDOI
Redefining the R1 resection in pancreatic cancer.
Caroline S. Verbeke,D. Leitch,Krishna V. Menon,Michael J. McMahon,P. J. Guillou,Alan Anthoney +5 more
TL;DR: The aim of this study was to assess the influence of standardized pathological examination on the reporting of RM status in pancreatic head adenocarcinoma.
Journal Article
Effect of adjuvant chemotherapy with fluorouracil plus folinic acid or gemcitabine vs observation on survival in patients with resected periampullary adenocarcinoma: the ESPAC-3 periampullary cancer randomized trial
John P. Neoptolemos,Malcolm J. Moore,Trevor Cox,Juan W. Valle,Daniel H. Palmer,Alec McDonald,Rodney William Carter,Niall C. Tebbutt,Christos Dervenis,D. Smith,Bengt Glimelius,Richard Charnley,François Lacaine,Scarfe Ag,Middleton,Alan Anthoney,Paula Ghaneh,Christopher Halloran,Markus M. Lerch,Attila Oláh,Charlotte L. Rawcliffe,Caroline S. Verbeke,Fiona Campbell,M.W. Büchler +23 more
TL;DR: Among patients with resected periampullary adenocarcinoma, adjuvant chemotherapy, compared with observation, was not associated with a significant survival Benefit in the primary analysis; however, multivariable analysis adjusting for prognostic variables demonstrated a statistically significant survival benefit associated with adjuant chemotherapy.
Journal ArticleDOI
European experts consensus statement on cystic tumours of the pancreas.
Marco Del Chiaro,Caroline S. Verbeke,Roberto Salvia,Günter Klöppel,Jens Werner,Colin J. McKay,Helmut Friess,Riccardo Manfredi,Eric Van Cutsem,Matthias Löhr,Ralf Segersvärd,L. Abakken,Mustapha Adham,N. Albin,Å. Andrén-Sandberg,Urban Arnelo,Marco J. Bruno,Djuna L. Cahen,Carla Cappelli,Guido Costamagna,M Del Chiaro,G. Delle Fave,Irene Esposito,Massimo Falconi,Helmut Friess,Paula Ghaneh,I. P. Gladhaug,Stephan L. Haas,Truls Hauge,Jakob R. Izbicki,Günther Klöppel,Markus M. Lerch,Lars Lundell,Jutta Lüttges,M. Löhr,R. Manfredi,Julia Mayerle,C. McKay,Kofi Oppong,Aldis Pukitis,Elena Rangelova,Thomas Rösch,Roberto Salvia,Richard D. Schulick,R. Segersvärd,T. Sufferlein,E. Van Cutsem,S. van der Merwe,C. Verbeke,J. Werner,Giuseppe Zamboni +50 more
TL;DR: Diagnostic computerized tomography and/or magnetic resonance imaging are indicated in all patients with cystic lesion of the pancreas and in lesions with a suspicion of malignancy, otherwise organ preserving procedures may be considered.